Form 4 KALOBIOS PHARMACEUTICALS For: Nov 18 Filed by: Shkreli Martin
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Macrocure (MCUR) Ramps Higher
November 20, 2015 10:47 AM ESTMacrocure (NASDAQ: MCUR) shares advanced Friday, rising 50%. Some traders tied the moved to recent gains in KaloBios Pharma (NASDAQ: KBIO) and Macrocure's 'thin' 6.2 million share float.
... MoreFiling Shows Shkreli Bought Added 440K KaloBios Pharma (KBIO) Shares on 11/18 at $2.02
November 19, 2015 1:03 PM ESTMartin Shkreli issues another Form 4 showing an additional purchase of 444,000 KaloBios Pharma (NASDAQ: KBIO) shares made on 11/18 at $2.02.
... More